Document:

<PAGE>

                                                                   EXHIBIT 10.61

                          AGREEMENT AND GENERAL RELEASE
                          -----------------------------

         THIS AGREEMENT AND GENERAL RELEASE ("Agreement") is made and entered
into by and between E-OIR Technologies, Inc. ("E-OIR"), Markland Technologies,
Inc. ("Markland") and Gregory Williams, a natural person residing in
Fredericksburg, Virginia and his heirs, executors, administrators, successors,
and assigns (collectively referred to throughout this Agreement as "Mr.
Williams").

         WHEREAS, Gregory Williams is currently employed as the Executive Vice
President, Chief Financial Officer and Chief Operating Officer of E-OIR
Technologies, Inc.; and

         WHEREAS, Mr. Williams is also on the board of directors of Markland
Technologies and has been requested to resign his position because of the
outstanding litigation between Markland and Mr. Williams' family member; and

         WHEREAS, an adverse condition to Mr. Williams' employment has occurred
which entitles him to voluntarily resign his employment without affecting the
obligations Markland and E-OIR have to Mr. Williams under that certain
Promissory Note provided to Mr. Williams to redeem his shares in E-OIR (the
"Promissory Note"); and

         WHEREAS, the parties wish to resolve all disputes, known and unknown,
which have occurred up to the date of this agreement.

         NOW therefore for good and valuable consideration, the parties agree as
follows:

         1. ADVERSE CONDITION OF EMPLOYMENT. E-OIR agrees that it has made
decisions which are in the best interest of the company which have adversely
affected and will continue to adversely affect Mr. Williams' employment at
E-OIR.

         2. LAST DAY OF EMPLOYMENT. Mr. William's last day of employment with
E-OIR will be the date all parties have executed the Agreement.

         3. RESIGNATION AS DIRECTOR. Mr. Williams' resignation as a director of
Markland will be effective the date all parties have executed the Agreement.

         4. PAYMENT OF VACATION LEAVE. Mr. Williams shall receive payment for
accrued and unused vacation time (180 hours) in a final paycheck which will be
issued and sent on the next regular payday after the execution of this
Agreement. E-OIR shall deduct from all amounts payable under this Agreement,
including amounts payable under benefit plans, all federal, state, local and
other taxes required by law to be withheld with respect to such payments.

         5. CONSIDERATION. In consideration for signing this Agreement and
General Release and complying with the promises made herein, and in addition to
providing Mr. Williams with his accrued, unused vacation, and any and all
reimbursements for reasonable E-OIR business-related expenses incurred while
employed by E-OIR, provided such expenses were incurred in accordance with E-OIR
policy and are submitted by November 30, 2004, E-OIR and Markland agree as
follows:

                                       1

<PAGE>

                  (a) E-OIR shall pay Mr. Williams twelve (12) months severance
pay in the amount of Two Hundred Thousand Dollars ($200,000). E-OIR shall deduct
any amounts payable under benefit plans and all federal, state, local and other
taxes required by law to be withheld with respect to such payments. Severance
payments shall be made on a monthly basis beginning November 15, 2004.

                  (b) Mr. Williams shall be entitled to retain all benefits
provided to senior executives at E-OIR through December 31, 2005, including but
not limited to medical and dental coverage. To the extent continuation
requirements of COBRA apply prior to December 31, 2005, E-OIR shall pay for the
cost of said coverage beginning on the last day of employment and ending on the
date Mr. Williams finds new employment, but no later than December 31, 2005. Mr.
Williams agrees to promptly notify E-OIR upon securing new employment offering
insurance benefits comparable to those provided to senior executives at E-OIR.

                  (c) Mr. Williams' non-statutory stock options granted by
Markland Technologies, Inc. under the 2004 Stock Incentive Plan which would have
been vested on or before July 31, 2006 shall become fully vested upon execution
of the Agreement. These stock options must be exercised by December 31, 2005 at
the rates at which Mr. Williams was granted such options or they will be
forfeited. Mr. Williams acknowledges that all other stock options provided to
Mr. Williams at the sale of E-OIR, pursuant to the 2004 Stock Incentive Plan,
which are not vested at the time of his separation of employment from E-OIR or
through this Agreement may not be exercised at any time in the future.

                  (d) The Promissory Note is a valid and ongoing obligation of
Markland and E-OIR Technologies to Mr. Williams.

         6. PROMISSORY NOTE REMAINS IN FULL EFFECT. Mr. Williams does not in any
way release his right to the payments set forth in the Promissory Note.

         7. EMPLOYEE PROPRIETARY INFORMATION AND NONCOMPETITION AGREEMENT.

                  (a) Mr. Williams reaffirms his obligation to comply with the
Employee Propriety Information and Noncompetition Agreement signed during his
employment (Attached as Exhibit A).

                  (b) In addition, Mr. Williams agrees for twelve (12) months
from the date of this Agreement or from the date of entry by a court of
competent jurisdiction of a final judgment enforcing this covenant (whichever is
later), he will not either directly or indirectly, own, manage, operate,
control, be an officer or director or be employed by any Competitor. For
purposes of this Agreement, a Competitor is defined as any entity which during
his employment with E-OIR provides the same or similar services to customers of

                                       2

<PAGE>

E-OIR within the State of Virginia and where the Company possesses an active
contract, subcontract, delivery order or purchase order for support. For twelve
(12) months from the date of this Agreement or from the date of entry by a court
of competent jurisdiction of a final judgment enforcing the covenant (whichever
is later), Mr. Williams will not induce, solicit or cause to be solicited any
employee of E-OIR to leave his/her employment with E-OIR.

                  (c) The foregoing restrictions shall not be construed to
prohibit Mr. Williams' ownership of less than five percent of any class of
securities of any corporation which is engaged in any of the foregoing
businesses and has a class of securities registered pursuant to the Securities
Exchange Act of 1934, provided that such ownership represents a passive
investment and Mr. Williams is not in any way, either directly or indirectly,
involved in the management or has control of any such corporation or otherwise
takes any part in its business, other than exercising his rights as a
shareholder.

         8. RETURN OF EQUIPMENT AND CONFIDENTIAL INFORMATION. Mr. Williams
agrees he has returned all Confidential Information and any other E-OIR or
Markland property including, but not limited to, computer, fax machine, printer,
and ALL other related equipment.

         9. GENERAL RELEASE OF CLAIMS. Mr. Williams knowingly and voluntarily
releases and forever discharges, to the extent permitted by law, E-OIR,
Markland, their parent corporation, affiliates, subsidiaries, divisions,
insurers, successors and assigns and their current and former employees,
officers, directors and agents thereof, individually and in their corporate
capacities (collectively referred to throughout the remainder of this Agreement
as "Released Parties"), of and from any and all claims, known and unknown,
asserted or unasserted, that Mr. Williams has or may have against the Released
Parties as of the date of execution of this Agreement, except as noted in this
Agreement including, but not limited to, any alleged violation of:

         Title VII of the Civil Rights Act of 1964, as amended; The Civil Rights
           Act of 1991;
         Sections 1981 through 1988 of Title 42 of the United States Code, as
           amended;
         The Mr. Williams Retirement Income Security Act of 1974, as amended;
         The Immigration Reform and Control Act, as amended;
         The Americans with Disabilities Act of 1990, as amended;
         The Age Discrimination in Employment Act of 1967, as amended;
         The Workers Adjustment and Retraining Notification Act, as amended;
         The Sarbanes-Oxley Act of 2002;
         The Occupational Safety and Health Act, as amended;
         The Virginia Human Rights Act, as amended;
         The Virginia Statutory Provisions Regarding Retaliation/Discrimination
           for Filing a Workers' Compensation Claim, as amended;
         The Virginia Equal Pay Act, as amended;
         The Virginians With Disabilities Act, as amended;
         The Virginia AIDS Testing Law, as amended;
         The Virginia Wage Payment and Hour Laws, as amended;
         The Virginia Occupational Safety and Health (VOSH) Law, as amended;
         Any other federal, state or local civil or human rights law or
           any other local, state or federal law, regulation or ordinance;
         Any public policy, contract, tort, or common law; or
         Any allegation for costs, fees, or other expenses including attorneys'
           fees incurred in these matters.

                                       3

<PAGE>

         E-OIR and Markland, along with their parent corporation, affiliates,
subsidiaries, divisions, insurers, successors and assigns and their current and
former employees, officers, directors and agents thereof, individually and in
their corporate capacities hereby release Mr. Williams from any and all claims,
known and unknown, asserted or unasserted, which E-OIR or Markland have or may
have against Mr. Williams, including but not limited to claims arising out of
the sale of his ownership in E-OIR, his employment at E-OIR or his position as a
director of Markland Technologies as of the date of execution of this Agreement
except as specifically reserved in this Agreement.

         10. INDEMNIFICATION. E-OIR and Markland shall defend, hold harmless and
indemnify Mr. Williams from and against all claims, actions, damages,
liabilities or losses, whether joint or several, to which Mr. Williams may
become subject which arise out of or are based upon actions taken within the
scope of his employment at E-OIR for the benefit of E-OIR or in his role as a
director of Markland Technologies.

         11. AFFIRMATIONS. Mr. Williams affirms that to the best of his
knowledge he has not filed, caused to be filed, or presently is a party to any
claim, complaint, or action against Released Parties in any forum or form. Mr.
Williams further affirms he has been paid and/or has received all leave (paid or
unpaid), compensation, wages, bonuses, commissions, and/or benefits to which he
may be entitled and that no other leave (paid or unpaid), compensation, wages,
bonuses, commissions and/or benefits are due to him, except as provided in this
Agreement and except for Mr. Williams' final paycheck. Mr. Williams affirms that
he has no known workplace injuries or occupational diseases and has been
provided and/or has not been denied any leave requested under the Family and
Medical Leave Act or related state or local leave or disability laws.

         E-OIR and Markland affirm that they have been paid for any amounts due
from Mr. Williams and that to the best of their knowledge all property and
equipment has been returned.

         12. ENFORCEMENT OF AGREEMENT. Mr. Williams acknowledges and agrees that
compliance with the fair and reasonable covenants set forth in Paragraph 7 of
this Agreement are necessary to protect the business and goodwill of E-OIR and
that any breach of Paragraph 7, or any subparagraphs hereof, will result in
irreparable and continuing harm to E-OIR, for which money damages may not
provide adequate relief. Accordingly, in the event of any breach or anticipatory
breach of Paragraph 7 of this Agreement by Mr. Williams, E-OIR and Mr. Williams
agree that E-OIR shall be entitled to the following particular forms of relief
as a result of such breach, in addition to any remedies otherwise available at
law or equity: (a) injunctions, both preliminary and permanent, enjoining or
restraining such breach or anticipatory breach, and Mr. Williams hereby consents
to the issuance thereof, forthwith and without bond, by any court of competent
jurisdiction which has personal jurisdiction over Mr. Williams; and (b) the
prevailing party shall be entitled to recover all reasonable sums and costs,
including attorneys' fees, incurred by the prevailing party in any such action.

                                       4

<PAGE>

         13. CONFIDENTIALITY. The parties agree to keep confidential and not
disclose any of the terms, conditions, amounts or any other details of this
Agreement to any person, provided that any party may make disclosure (1) to
their attorneys consulted by such party to understand the interpretation,
application, or legal effect of this Agreement, (2) as required by law or
regulation of any governmental authority, or to the extent necessary to verify
to tax authorities the nature of the payments made hereunder, (3) to the extent
necessary to enforce this Agreement by legal action, (4) in the case of Mr.
Williams, only with respect to the information in those sections relating to
financial terms, obtaining financial planning or (5) to Joseph R. Moulton, Sr.
provided such disclosure is limited solely to disclosure of the release given to
Markland and E-OIR under the Agreement.

         Notwithstanding this provision, the parties may disclose to third
parties that the Agreement is confidential and cannot be discussed. In addition,
notwithstanding the confidentiality provision, Mr. Williams shall be permitted
to disclose to potential employers Paragraph 7 of the Agreement and the Employee
Proprietary Information and Noncompetition Agreement provision.

         In the event of a breach of this provision by Mr. Williams by
disclosing in writing any terms of the Agreement, no further benefits or
severance payments shall be due and payable. If an action is brought on the
breach of this provision, the prevailing party shall be entitled to its
attorneys' fees and costs in bringing or defending any action.

         14. PUBLIC DISCLOSURE OF RESIGNATIONS. No public statement shall be
made by E-OIR prior to Mr. Williams' last date of employment. Thereafter, the
parties shall reasonably agree upon the content of any such public disclosure.
In response to any questions on Mr. Williams' resignation as a director, the
parties shall state that Mr. Williams resigned for personal reasons. In response
to questions on Mr. Williams' departure as an employee, the parties shall state
that Mr. Williams has decided to leave to pursue other opportunities and they
wish each other continued success.

         15. NONDISPARAGEMENT. The parties further agree that they will not
disparage each other.

         16. NO PRECEDENT. The parties agree that the terms, conditions and
details of this Agreement are unique and are addressed to the specific
circumstances of their relationship and accommodation of the parties and shall
in no event provide a precedent, policy or practice for treatment of other
employees of E-OIR in the future.

         17. GOVERNING LAW AND INTERPRETATION. This Agreement shall be governed
by and conform with the laws of the Commonwealth of Virginia without regard to
its conflict of laws provision. In the event any party breaches any provision of
this Agreement, the parties affirm that either may institute an action to
specifically enforce any term or terms of this Agreement. Should any provision
of this Agreement be declared illegal or unenforceable by any court of competent
jurisdiction and cannot be modified to be enforceable, excluding the general
release language, such provision shall immediately become null and void, leaving
the remainder of this Agreement in full force and effect. No provision shall be
construed against one party on the basis of which party drafted the language in
the Agreement.

                                       5

<PAGE>

         18. NO ADMISSION OF WRONGDOING. The parties agree that neither this
Agreement nor the furnishing of the consideration for this Agreement shall be
deemed or construed at anytime, for any purpose, as an admission by either party
of any liability or unlawful conduct of any kind.

         19. AMENDMENT. This Agreement may not be modified, altered or changed
except upon express written consent of both parties wherein specific reference
is made to this Agreement.

         20. ENTIRE AGREEMENT. This Agreement and General Release sets forth the
entire agreement between the parties hereto, and fully supersedes any prior
agreements or understandings between the parties. Mr. Williams acknowledges that
he has not relied on any representations, promises, or agreements of any kind
made to him in connection with his decision to accept this Agreement and General
Release, except for those set forth in this Agreement and General Release.

                  IN WITNESS WHEREOF, the parties hereto knowingly and
voluntarily executed this Agreement and General Release as of the date set forth
below:

                                       6

<PAGE>

                                                      E-OIR, TECHNOLOGIES, INC.

Date:                                                 By:/S/ JOSEPH MACKIN
       -------------------------------------             -----------------------
                                                               Joseph Mackin

                                                      MARKLAND TECHNOLOGIES

Date:                                                 By:/S/ ROBERT TARINI
       -------------------------------------             -----------------------
                                                               Robert Tarini

Date:                                                 /S/ GREGORY WILLIAMS
       -------------------------------------          --------------------------
                                                               Gregory Williams

                                       7Confidential treatment has been requested for portions of this exhibit. The copy
filed  herewith  omits  the  information  subject  to a confidentiality request.
Omissions  are  designated  ******. A complete version of this exhibit has been
filed  separately  with  the  Securities  and  Exchange  Commission.

AMENDMENT  OF  SOLICITATION/MODIFICATION  OF  CONTRACT     PAGE  OF  PAGES
                                                           1   of    9

1.  CONTRACT  ID  CODE  -  U  -  CPFF
2.  AMENDMENT/MODIFICATION  NO  -  P00009
3.  EFFECTIVE  DATE  -  August  20,  2004
4.  REQUISITION/PURCHASE  REQ.NO.  -  SEE  SCHEDULE
5.  PROJECT  NO  (If  applicable)
6.  ISSUED  BY  AFRL/PK8VI  CODE  FA9453
     DET  8  AF  RESEARCH  LABORATORY
     DIRECTORATE  OF  CONTRACTING\PK
     2251 MAXWELL  AVE  SE
     KIRTLAND  AFB  ,  NM  87117-5773
     SHARI  D.  BARNETT  (505)  846-6189
     shari.barnett@kirtland.af.mil
7.  ADMINISTERED  BY  (If  other  than  Item  6)  CODE  S0514A
     DCMA  SAN  DIEGO
     7675  DAGGET  ST  SUITE  200
     SAN  DIEGO  CA  92111-2241
8.  NAME  AND  ADDRESS  OF  CONTRACTOR (No., street, county, State and ZIP Code)
     SPACEDEV,  INC
     13855  STOWE  DR
     POWAY  CA  92064
     (858)  375-2011
     CODE  1J2T1  FACILITY  CODE
(X)  9A.  AMENDMENT  OF  SOLICITATION  NO.
(  )  9B.  DATED  (SEE  ITEM  11)

     10A.  MODIFICATION  OF  CONTRACT/ORDER  NO.  F29601-03-C-0036
X
     10B.  DATED  (SEE  ITEM  13)  -  28  MAR  2003

11.  THIS  ITEM  ONLY  APPLIES  TO  AMENDMENTS  OF  SOLICITATIONS
[  ]  The  above  numbered solicitation is amended as set forth in Item 14.  The
hour  and  date  specified for receipt of Offers  [  ]  is extended, [  ] is not
extended.
Offers  must  acknowledge  receipt  of this amendment prior to the hour and date
specified in the solicitation or as amended, by one of the following methods:(a)
By  completing  Items 8 and 15, and returning _____ copies of the amendment; (b)
By  acknowledging  receipt of this amendment on each copy of the offersubmitted;
or   (c)  By  separate  letter  or  telegram  which  includes a reference to the
solicitation  and  amendment  numbers.      FAILURE OF YOUR ACKNOWLEDGMENT TO BE
RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND
DATE  SPECIFIED  MAY RESULT IN REJECTION OF YOUR OFFER.     If by virtue of this
amendment  you  desire  to change an offer already submitted, such change may be
made  by telegram or letter, provided each telegram or letter makes reference to
the  solicitation  and this amendment, and is received prior to the opening hour
and  date  specified.

12.  ACCOUNTING  AND  APPROPRIATION  DATA  (If  required)  -  SEE  SCHEDULE
13.  THIS ITEM APPLIES ONLY TO MODIFICATION OF CONTRACTS/ORDERS, IT MODIFIES THE
CONTRACT/ORDER  NO.  AS  DESCRIBED  IN  ITEM  14.
     (X)  A.  THIS  CHANGE  ORDER  IS ISSUED PURSUANT TO: (____) THE CHANGES SET
     FORTH  IN  ITEM  14  ARE  MADE  IN  THE  CONTRACT  ORDER  NO.  ITEM  10A.
     (  )  B.  THE  ABOVE  NUMBERED  CONTRACT/ORDER  IS  MODIFIED TO REFLECT THE
     ADMINISTRATIVE  CHANGES  (such  as  changes in paying office, appropriation
     data,  etc.)  SET  FORTH  IN  ITEM  14,  PURSUANT  TO  THE AUTHORITY OF FAR
     43.103(b).
     (X)  C.  THIS  SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY
     OF:  52.243-2,  Alt  V  Changes  --  Cost  Reimbursement
     (  )  D.  OTHER  (Specify  type  of  modification  and  authority)
     E.  IMPORTANT: Contractor [ ] is not, [X] is required to sign this document
     and  return  1  copies  to  the  issuing  office.
14.  DESCRIPTION  OF  AMENDMENT/MODIFICATION (Organized by UCF section headings,
including  solicitation/contract subject matter where feasible.) SUBJECT: Change
to  Statement  of  Work  to  add  Mini-MTV  Study  Task
     Previous Amount Allotted: $2,230,488.00
     This  Action:             $  149,201.00
     Total  Amount  Allotted:  $2,379,689.00.
Except  as  provided herein, all terms and conditions of the document referenced
in  Item  9A  or 10A, as heretofore changed, remains unchanged and in full force
and  effect.

15A.  NAME  AND  TITLE  OF  SIGNER  (Type  or  print)
15B.  CONTRACTOR/OFFEROR
             /s/ Richard B. Slansky, CFO
             ---------------------------
             (Signature  of  person  authorized  to  sign)
15C.  DATE  SIGNED
      August 20, 2004
16A.  NAME  AND  TITLE  OF  SIGNER  (Type  or  print)
            SHARI  D.  BARNETT
            Contracting  Officer
16B.  UNITED  STATES  OF  AMERICA
     BY:  /s/ Shari D. Barnett
     -------------------------
    (Signature  of  Contracting  Officer)
16C.  DATE  SIGNED
      20 August 2004

NSN  7540-01-152-8070     30-105                 STANDARD  FORM  30  (REV.10-83)

                                                         F29601-03-C-0036 P00009
                                                         -----------------------
                                                                     PAGE 1 OF 9

Confidential treatment has been requested for portions of this exhibit. The copy
filed  herewith  omits  the  information  subject  to a confidentiality request.
Omissions  are  designated  ******. A complete version of this exhibit has been
filed  separately  with  the  Securities  and  Exchange  Commission.

1.  PURPOSE:  The  contract  is  hereby  modified to add the Mini-MTV study task
under  CLIN  0007.  As  a result of this action, the contract is modified in the
following  particulars.

2.  CONTRACT  PRICE:  The  contract  price  is  changed  from  $2,477,411.00  to
$2,626,612.00,  an  increase  of  $149,201.00.

3.  AMOUNT  OBLIGATED:   The  total  amount obligated to the contract is changed
from  $2,230,488.00  to  $2,379,689.00,  an  increase  of  $149,201.00

4.  CHANGES  TO  THE  CONTRACT:

     a.  SF26,  Block 15G - Delete $2,477,411.00 and replace with $2,626,612.00.

     b.  PART  I  -  THE  SCHEDULE,  SECTION  B  -  SUPPLIES  OR  SERVICES  AND
PRICES/COSTS

      (1)  Add  CLIN  0007  as  follows:

                                     Qty                   Unit  Price
ITEM     SUPPLIES  OR  SERVICES     Purch  Unit     Total  Item  Amount
----     ----------------------     -----------     -------------------

STUDY  TASK
-----------

0007      CLIN  Establish             1                     $149,201.00
                                      Lot                   $149,201.00
          Noun:     MINI  -  MTV  STUDY
          ACRN:     9
          NSN:     N  -  Not  Applicable
          DD1423  is  Exhibit:     A
          Contract  type:     U  -  COST  PLUS  FIXED  FEE
          Inspection:     DESTINATION
          Acceptance:     DESTINATION
          FOB:     DESTINATION
          Descriptive  Data:
          The contractor shall furnish all labor, supplies, hardware, materials,
          travel,  facilities,  and  other  direct  costs reasonably required to
          accomplish  the  Statement of Work entitled "Mini-MTV Study", dated 21
          Jul  04  hereby  incorporated  by  Attachment  2.

STUDY  TASK
-----------

000701     CLIN  Establish
           Noun:     Funding  Info  Only
           ACRN:     AF     +$149,201.00
           PR/MIPR:     GAFRL046251935     $149,201.00

                                                         F29601-03-C-0036 P00009
                                                         -----------------------
                                                                     PAGE 2 OF 9

Confidential treatment has been requested for portions of this exhibit. The copy
filed  herewith  omits  the  information  subject  to a confidentiality request.
Omissions  are  designated  ******. A complete version of this exhibit has  been
filed  separately  with  the  Securities  and  Exchange  Commission.

       (2)  Revise  AFMC  5352.216-9001 PAYMENT OF FEE (AFMC) (CPFF)  (Jul 1997)
as  follows:

The  estimated  cost  and fee for this contract are shown below.  The applicable
fixed  fee  or  target fee set forth below may be increased or decreased only by
negotiation  and  modification  of  the  contract for added or deleted work.  As
determined  by  the  contracting  officer,  it  shall  be paid as it accrues, in
regular  installments  based  upon  the percentage of completion of work (or the
expiration  of  the  agreed-upon  period(s)  for  term  contracts).

BASIC  EFFORT:
Estimated  Cost:  $1,575,671
Fixed  Fee:  $95,242.00

Applicable  to  following  Line  Items:  CLINs  0001-0003

OPTION  1:

Estimated  Cost:  $757,275.00
Fixed  Fee:  $49,223.00

Applicable  to  following  Line  Items:  CLINs  0004-0006

CLIN  0007:

Estimated  Cost:  $140,095
Fixed  Fee:  $9,106

   (3)  Revise  B054  IMPLEMENTATION  OF  LIMITATION  OF  FUNDS  (Feb  2003)  as
follows:

          (a)  The  sum  allotted  to this contract and available for payment of
     costs  under  CLINs  0001-0003  through  completion  in accordance with the
     clause  in  Section I entitled "Limitation of Funds" is $1,575,671. The sum
     allotted  to  this  contract and available for payment of costs under CLINs
     0004-0006  through  15  Oct  04  in accordance with the clause in Section I
     entitled  "Limitation  of  Funds"  is $525,423.00. The sum allotted to this
     contract  and  available  for  payment  of  costs  under  CLIN 0007 through
     completion  is  $140,095.

          (b) In addition to the amount allotted under the "Limitation of Funds"
     clause, the additional amount of $95,242.00 is obligated for payment of fee
     for  work  completed  under  CLINs  0001-0003.  In  addition  to the amount
     allotted  under  the "Limitation of Funds" clause, the additional amount of
     $34,152.00  is  obligated for payment of fee for work completed under CLINs
     0004-0006.  In  addition  to  the  amount allotted under the "Limitation of
     Funds"  clause, the additional amount of $9,106.00 is obligated for payment
     of  fee  for  work  completed  under  CLIN  0007.

     c.  PART I - THE SCHEDULE, SECTION C - DESCRIPTION/SPECS/STATEMENT OF WORK:

     Revise C003 INCORPORATED DOCUMENTS/REQUIREMENTS  (Apr 1998), paragraph 1 as
follows:

1.  Work  called  for by the contract line items specified in SECTION B shall be
performed  in  accordance  with  the  following:

   The  contractor's  technical  proposal  entitled  "Small  Shuttle-Compatible
Propulsion  Module", dated 30 August 02, is hereby incorporated by reference and
constitutes the Statement of Work (SOW) as amended 15 Apr 04 for CLINs 0004-0006
and  the  "Mini-MTV  Study  Task"  dated  21  Jul  04  for  CLIN  0007.

                                                         F29601-03-C-0036 P00009
                                                         -----------------------
                                                                     PAGE 3 OF 9

Confidential treatment has been requested for portions of this exhibit. The copy
filed  herewith  omits  the  information  subject  to a confidentiality request.
Omissions  are  designated  ******. A complete version of this exhibit has  been
filed  separately  with  the  Securities  and  Exchange  Commission.

  d.  PART  I  -  THE  SCHEDULE,  SECTION  E  -  INSPECTION  AND  ACCEPTANCE

        Revise  as  follows:

E006  RECEIVING  REPORT  (DD  FORM  250)  MAILING  ADDRESS  (APR  1998)
(a)  Submit  original  DD Form(s) 250 for hardware deliverables under CLINs 0003
and  0006  of  this  contract  to  the  following  address:

               Lt  John  Madsen
               AFRL/VSE-L
               3550  Aberdeen  Street  SE
               Kirtland  AFB,  NM  87117-5776

Submit  original  DD  Form(s)  250  for  deliverables  under CLIN  0007 of  this
contract  to  the  following  address:

               Dr.  Russ  Partch
               AFRL/VSE
               3550  Aberdeen  Street  SE
               Kirtland  AFB,  NM  87117-5776

     (b)   Shipment  addresses are specified in Section F of the schedule and/or
on  the  Contract  Data  Requirements  List.

     (c)  PROCESSING  STATUS.  Any  inquiry  as to the processing status of a DD
Form  250  for  CLINs  0001  -  0006  should  be  made  to the following office:

               Lt  John  Madsen
               AFRL/VSE-L
               3550  Aberdeen  Street  SE
               Kirtland  AFB,  NM  87117-5776

Any inquiry as to the processing status of a DD Form 250 for CLIN 0007 should be
made  to  the  following  office:

               Dr.  Russ  Partch
               AFRL/VSE
               3550  Aberdeen  Street  SE
               Kirtland  AFB,  NM  87117-5776
               .
     (d)  Submit  original  Z-coded  DD  Form  250  for the final Scientific and
Technical  Report  for  CLINs  0002  and  0005  to  the  following  address:

               Lt  John  Madsen
               AFRL/VSE-L
               3550  Aberdeen  Street  SE
               Kirtland  AFB,  NM  87117-5776

                                                         F29601-03-C-0036 P00009
                                                         -----------------------
                                                                     PAGE 4 OF 9

Confidential treatment has been requested for portions of this exhibit. The copy
filed  herewith  omits  the  information  subject  to a confidentiality request.
Omissions  are  designated  ******. A complete version of this exhibit has been
filed  separately  with  the  Securities  and  Exchange  Commission.

     (e)  PROCESSING  STATUS.  Any  inquiry  as  to the processing status of the
Z-coded  DD  Form  250  should  be  made  to  the  following  office:

               Lt  John  Madsen
               AFRL/VSE-L
               3550  Aberdeen  Ave  SE
               Kirtland  AFB,  NM  87117-5776

E007  INSPECTION  AND  ACCEPTANCE  AUTHORITY  (APR  1998)
Inspection  and  acceptance  for all Contract and Exhibit Lines or Subline Items
shall  be  accomplished  by  the Program Manager, Air Force Research Laboratory,
CLINS  0001-0006:
Lt.  John  Madsen
AFRL/VSE-L
3550  Aberdeen  Ave  SE
Kirtland  AFB,  NM  87117-5776

CLIN  0007:
Dr.  Russ  Partch
AFRL/VSE
3550  Aberdeen  Ave  SE
Kirtland  AFB,  NM  87117-5776  .

    e.  PART  I  -  THE  SCHEDULE  SECTION  F  -  DELIVERIES  OR  PERFORMANCE

      (1)   Add  CLIN  0007  as  follows:

                                              SHIP     MARK     TRANS
ITEM     SUPPLIES SCHEDULE DATA       QTY     TO       FOR      PRI      DATE
----     ------------------------     ---     ----     ---      -----    ----

0007                                   1       FA9453           18  Apr  2005

          Noun:                        MINI  -  MTV  STUDY
          ACRN:                        9
          Descriptive  Data:
          The  contractor  shall deliver the draft final report no later than 18
          Jan  05.  The final report shall be delivered no later than 18 Apr 05.
          Instructions  are  contained  in  the  Mini-MTV  Study  Task.

                                                         F29601-03-C-0036 P00009
                                                         -----------------------
                                                                     PAGE 5 OF 9

Confidential treatment has been requested for portions of this exhibit. The copy
filed  herewith  omits  the  information  subject  to a confidentiality request.
Omissions  are  designated  ******. A complete version of this exhibit has been
filed  separately  with  the  Securities  and  Exchange  Commission.

                (2)  Revise  as  follows:

F007  SHIPMENT  ADDRESS  (SEP  1997)
CLINs  0001-0006:

AFRL/VSE-L
Attn:  Lt.  John  Madsen
3550  Aberdeen  Ave  SE
Kirtland  AFB  NM  87117-5776

CLIN  0007:

Dr.  Russ  Partch
AFRL/VSE
3550  Aberdeen  Ave  SE
Kirtland  AFB,  NM  87117-5776

AFRL/VSIR
Attn:  Technical  Reports
3550  Aberdeen  Ave  SE
Kirtland  AFB  NM  87117-5776

AFRL/VSOT
Attn:  SBIR  Program  Manager
3550  Aberdeen  Ave  SE
Kirtland  AFB  NM  87117-5776

Det  8  AFRL/PKVI
Attn:  Shari  Barnett
2251  Maxwell  Ave  SE
Kirtland  AFB  NM  87117-5773

ACO  -  See  Block  7  of  SF  26

     f.  PART  I  -  THE  SCHEDULE,  SECTION  G  -  CONTRACT ADMINISTRATION DATA

          (1)  Add  as  follows:
                              Obligation
ACRN     Appropriation/Lmt  Subhead/Supplemental  Accounting  Data     Amount
----     ---------------------------------------------------------     ------

AF        ACRN  Establish                                         $149,201.00
          57   43600  294  ETLA  65A003  000070  00000  64421F  503000  F03000
          New  ACRN  Amount:                  $149,201.00
          Funding  breakdown:     On  CLIN  000701:     +$149,201.00
          PR/MIPR:          GAFRL046251935               $149,201.00
          Descriptive  data:
          MIPR  #N000SY04730028

                                                         F29601-03-C-0036 P00009
                                                         -----------------------
                                                                     PAGE 6 OF 9

Confidential treatment has been requested for portions of this exhibit. The copy
filed  herewith  omits  the  information  subject  to a confidentiality request.
Omissions  are  designated  ******. A complete version of this exhibit has been
filed  separately  with  the  Securities  and  Exchange  Commission.

        (2)  Revise  as  follows:

G002  PROGRAM  MANAGER  (MAY  1997)
Program  Manager:  CLINs  0001-0006:

AFRL/VSE-L,  Lt  John  Madsen
505-846-2947

CLIN  0007:
AFRL/VSE,  Dr.  Russ  Partch
505-846-8929

     (3)  Revise  the table in G005 PAYMENT INSTRUCTIONS FOR MULTIPLE ACCOUNTING
CLASSIFICATION  CITATIONS  (Mar  2001)  as  follows:

Payment  for  all  effort  under  this  contract should be made in the order and
amounts  shown  in  the informational subline item(s) in Section B, CLIN 0001 of
the  contract  and  recapped below.  Exhaust the funds in each ACRN before using
funds  from  the  next  listed  ACRN.

ACRN          SUBCLIN  NO.     TOTAL  OBLIGATED
AA          000101                  $375,000.00
AB          000102                 -$375,000.00
AC          000103                  $680,488.00
AD          000104                  $375,000.00
AE          000105                  $240,425.00
AE          000401                  $559,575.00
AF          000701                  $149,201.00

Total                             $2,379,689.00

     g.  PART  I  -  THE  SCHEDULE,  SECTION  H,  SPECIAL  CONTRACT REQUIREMENTS

Revise  as  follows:

 H029  IMPLEMENTATION  OF  DISCLOSURE  OF  INFORMATION  (OCT  1997)
In  order  to  comply  with  DFARS  252.204-7000, Disclosure of Information, the
following copies of the information to be released are required at least 45 days
prior  to  the  scheduled  release  date:

     (a)  8  copy(ies)  to:  Office of Public Affairs, Office of Public Affairs,
Air  Force  Research  Laboratory
AFRL/VSO
3550  Aberdeen  SE
Kirtland  AFB,  NM  87117-5776

     (b)  1  copy(ies)  to:  Contracting  Officer,  Shari  Barnett
AFRL/PKVI
2251  Maxwell  Ave  SE
Kirtland  AFB,  NM  87117-5773

     (c)  1  copy(ies)  to:  Program  Manager,  CLINs  0001-0006:
Lt.  John  Madsen
AFRL/VSE-L
3350  Aberdeen  SE
Kirtland  AFB,  NM  87117-5776

                                                         F29601-03-C-0036 P00009
                                                         -----------------------
                                                                     PAGE 7 OF 9

Confidential treatment has been requested for portions of this exhibit. The copy
filed  herewith  omits  the  information  subject  to a confidentiality request.
Omissions  are  designated  ******. A complete version of this exhibit has been
filed  separately  with  the  Securities  and  Exchange  Commission.

CLIN  0007:  Dr.  Russ  Partch
AFRL/VSE
3550  Aberdeen  Ave  SE
Kirtland  AFB,  NM  87117-5776.

5.  This  Supplemental Agreement constitutes a full and equitable adjustment and
the  Contractor  releases  the  Government  from any and all liability under the
contract  for further equitable adjustments arising out of or in connection with
the changes effected hereby.  All other terms and conditions remain unchanged as
a  result  of  this  modification.

                                                         F29601-03-C-0036 P00009
                                                         -----------------------
                                                                     PAGE 8 OF 9

Confidential treatment has been requested for portions of this exhibit. The copy
filed  herewith  omits  the  information  subject  to a confidentiality request.
Omissions  are  designated  ******. A complete version of this exhibit has been
filed  separately  with  the  Securities  and  Exchange  Commission.

                                    Mini-MoTV
                           Additional SOW Requirements
                                    21 Jul 04

1.     Modify  the  MTV  preliminary  design  developed in Task 2 to address the
following  variations  in  potential  uses.

a.     [******]
b.     [******]
c.     [******]
d.     [******]
e.     [******]
f.     [******]
g.     [******]
h.     [******]
i.     [******]
j.     [******]

2.     4  months  task  duration  plus  four  months  for  final  report.
3.     Kickoff  meeting,  plus  three reviews including final review.  AFRL will
provide  briefing  on  advanced technologies that are available for inclusion in
the  study  during  the  kickoff  meeting.
4.     Final report: [******]. This will be a separate report from the original
final  report.
5.     Final  report  to  include:
a.     [******]
b.     [******]
c.     [******]
d.     [******]

                                                         F29601-03-C-0036 P00009
                                                         -----------------------
                                                                     PAGE 9 OF 9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}]]